James A Beswick

Years Active: 2018-2023
Publications (10 Years): 5

LifeArc

University of Manchester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

LifeArc

United Kingdom

Industrial Placement Trainee :: Medicinal Chemistry

Education History

University of Manchester

United Kingdom

PHD :: School of Medical Sciences

Publications

Paula I Seoane, James A Beswick, Andrew G Leach, Tessa Swanton, Lucy V Morris, Kevin Couper, Martin Lowe, Sally Freeman, David Brough
Squaramides enhance NLRP3 inflammasome activation by lowering intracellular potassium. Cell death discovery 9 (1) (2023)
Paula I Seoane, James A Beswick, Andrew G Leach, Tessa Swanton, Lucy V Morris, Kevin Couper, Martin Lowe, Sally Freeman, David Brough
Squaramides enhance NLRP3 inflammasome activation by lowering intracellular potassium. Cell death discovery 9 (1) (2023)
Paula I Seoane, James A Beswick, Andrew G Leach, Tessa Swanton, Lucy V Morris, Kevin Couper, Martin Lowe, Sally Freeman, David Brough
Squaramides enhance NLRP3 inflammasome activation by lowering intracellular potassium. Cell death discovery 9 (1) (2023)
Tessa Swanton, James A Beswick, Halah Hammadi, Lucy Morris, Daniel Williams, Stephane de Cesco, Lina El-Sharkawy, Shi Yu, Jack Green, John B Davis, Catherine B Lawrence, David Brough, Sally Freeman
Selective inhibition of the K+ efflux sensitive NLRP3 pathway by Cl- channel modulation. Chemical science 11 (43) (2020)
Alex G Baldwin, Victor S Tapia, Tessa Swanton, Claire S White, James A Beswick, David Brough, Sally Freeman
Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome. ChemMedChem 13 (4) (2018)

James A Beswick.css-eqlu8i{font-size:small;padding-left:4px;}